Common variable immunodeficiency phenotype due to CD19/CD81 deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:696881OMIM:613496
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Common variable immunodeficiency phenotype due to CD19/CD81 deficiency.

View clinical trials →

No actively recruiting trials found for Common variable immunodeficiency phenotype due to CD19/CD81 deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Common variable immunodeficiency phenotype due to CD19/CD81 deficiency community →

Specialists

2 foundView all specialists →
PM
Paul Szabolcs, MD
Pittsburgh, Pennsylvania
Specialist

Rare Disease Specialist

PI on 7 active trials
CY
Christian C Yost
SALT LAKE CITY, UT
Specialist
PI on 3 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Common variable immunodeficiency phenotype due to CD19/CD81 deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Common variable immunodeficiency phenotype due to CD19/CD81 deficiencyForum →

No community posts yet. Be the first to share your experience with Common variable immunodeficiency phenotype due to CD19/CD81 deficiency.

Start the conversation →

Latest news about Common variable immunodeficiency phenotype due to CD19/CD81 deficiency

Disease timeline:

New recruiting trial: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

A new clinical trial is recruiting patients for Common variable immunodeficiency phenotype due to CD19/CD81 deficiency

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Common variable immunodeficiency phenotype due to CD19/CD81 deficiency

Which specialists treat Common variable immunodeficiency phenotype due to CD19/CD81 deficiency?

2 specialists and care centers treating Common variable immunodeficiency phenotype due to CD19/CD81 deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.